Matilda Azis1, Gregory P Strauss2, Elaine Walker3, William Revelle1, Richard Zinbarg1, Vijay Mittal1. 1. Department of Psychology, Department of Psychiatry, Department of Medical Social Sciences, Institute for Policy Research, Institute for Innovations in Developmental Sciences, Northwestern University, Evanston, IL. 2. Department of Psychology, University of Georgia, Athens, GA. 3. Department of Psychology and Psychiatry, Emory University, Atlanta, GA.
Abstract
BACKGROUND: Negative symptoms occur early in the clinical high risk (CHR) state and indicate increased risk of conversion to psychotic disorder and poor functional outcome. However, while the negative symptom domain has shown to be parsimoniously explained by a 2-factor construct in schizophrenia, there has yet to be an established factor structure of negative symptoms in CHR. METHODS: 214 individuals meeting the Structured Interview for Psychosis-Risk Syndromes (SIPS) criteria for CHR were recruited through 3 active research programs in the United States. Exploratory Factor Analysis was conducted on the 6 negative symptom items of the SIPS, and factors were evaluated with respect to functional outcome and depression. RESULTS: Factor analysis indicated a 2-factor hierarchical model with 2 negative symptom dimensions reflecting volition (Occupational Functioning and Avolition) and emotion (Expression of Emotion, Experience of Emotion and Social Anhedonia). Linear Regression showed that the emotion factor was associated with poor social function, and the volition factor was associated with poor role function and depression. CONCLUSIONS: Similar to factor solutions identified in adults diagnosed with psychotic disorders, results indicated that the SIPS negative symptom subscale is not a unidimensional construct. Rather, the SIPS negative subscale has 2 distinct factors that have different associations with clinical outcome and should be interpreted independently. Results have significant relevance for informing the valid assessment and conceptual interpretation of early clinical phenomenology in the psychosis prodrome.
BACKGROUND: Negative symptoms occur early in the clinical high risk (CHR) state and indicate increased risk of conversion to psychotic disorder and poor functional outcome. However, while the negative symptom domain has shown to be parsimoniously explained by a 2-factor construct in schizophrenia, there has yet to be an established factor structure of negative symptoms in CHR. METHODS: 214 individuals meeting the Structured Interview for Psychosis-Risk Syndromes (SIPS) criteria for CHR were recruited through 3 active research programs in the United States. Exploratory Factor Analysis was conducted on the 6 negative symptom items of the SIPS, and factors were evaluated with respect to functional outcome and depression. RESULTS: Factor analysis indicated a 2-factor hierarchical model with 2 negative symptom dimensions reflecting volition (Occupational Functioning and Avolition) and emotion (Expression of Emotion, Experience of Emotion and Social Anhedonia). Linear Regression showed that the emotion factor was associated with poor social function, and the volition factor was associated with poor role function and depression. CONCLUSIONS: Similar to factor solutions identified in adults diagnosed with psychotic disorders, results indicated that the SIPS negative symptom subscale is not a unidimensional construct. Rather, the SIPS negative subscale has 2 distinct factors that have different associations with clinical outcome and should be interpreted independently. Results have significant relevance for informing the valid assessment and conceptual interpretation of early clinical phenomenology in the psychosis prodrome.
Authors: Julie Evensen; Jan Ivar Røssberg; Helene Barder; Ulrik Haahr; Wenche Ten Velden Hegelstad; Inge Joa; Jan Olav Johannessen; T K Larsen; Ingrid Melle; Stein Opjordsmoen; Bjørn Rishovd Rund; Erik Simonsen; Per Vaglum; Thomas McGlashan; Svein Friis Journal: Schizophr Res Date: 2012-05-23 Impact factor: 4.939
Authors: Tandy J Miller; Thomas H McGlashan; Joanna Lifshey Rosen; Lubna Somjee; Philip J Markovich; Kelly Stein; Scott W Woods Journal: Am J Psychiatry Date: 2002-05 Impact factor: 18.112
Authors: Ivy F Tso; Stephan F Taylor; Tyler B Grove; Tara Niendam; Steven Adelsheim; Andrea Auther; Barbara Cornblatt; Cameron S Carter; Roderick Calkins; J Daniel Ragland; Tamara Sale; William R McFarlane Journal: Early Interv Psychiatry Date: 2014-12-21 Impact factor: 2.732
Authors: Eva Velthorst; Dorien H Nieman; Hiske E Becker; Reinaud van de Fliert; Peter M Dingemans; Rianne Klaassen; Lieuwe de Haan; Thérèse van Amelsvoort; Don H Linszen Journal: Schizophr Res Date: 2009-03-09 Impact factor: 4.939
Authors: Gregory P Strauss; William R Keller; Robert W Buchanan; James M Gold; Bernard A Fischer; Robert P McMahon; Lauren T Catalano; Adam J Culbreth; William T Carpenter; Brian Kirkpatrick Journal: Schizophr Res Date: 2012-11-03 Impact factor: 4.939
Authors: Gregory P Strauss; Andrea Pelletier-Baldelli; Katherine Frost Visser; Elaine F Walker; Vijay A Mittal Journal: Schizophr Res Date: 2020-06-07 Impact factor: 4.939
Authors: Wing Chung Chang; Gregory P Strauss; Anthony O Ahmed; Sandra C Y Wong; Joe K N Chan; Edwin H M Lee; Sherry K W Chan; Christy L M Hui; Sydney H James; Hannah C Chapman; Eric Y H Chen Journal: Schizophr Bull Date: 2021-03-16 Impact factor: 9.306
Authors: Daniel J Hauke; André Schmidt; Erich Studerus; Christina Andreou; Anita Riecher-Rössler; Joaquim Radua; Joseph Kambeitz; Anne Ruef; Dominic B Dwyer; Lana Kambeitz-Ilankovic; Theresa Lichtenstein; Rachele Sanfelici; Nora Penzel; Shalaila S Haas; Linda A Antonucci; Paris Alexandros Lalousis; Katharine Chisholm; Frauke Schultze-Lutter; Stephan Ruhrmann; Jarmo Hietala; Paolo Brambilla; Nikolaos Koutsouleris; Eva Meisenzahl; Christos Pantelis; Marlene Rosen; Raimo K R Salokangas; Rachel Upthegrove; Stephen J Wood; Stefan Borgwardt Journal: Transl Psychiatry Date: 2021-05-24 Impact factor: 6.222
Authors: S Galderisi; A Mucci; S Dollfus; M Nordentoft; P Falkai; S Kaiser; G M Giordano; A Vandevelde; M Ø Nielsen; L B Glenthøj; M Sabé; P Pezzella; I Bitter; W Gaebel Journal: Eur Psychiatry Date: 2021-02-18 Impact factor: 5.361
Authors: Teresa Vargas; Anthony O Ahmed; Gregory P Strauss; Cassandra M Brandes; Elaine F Walker; Robert W Buchanan; James M Gold; Vijay A Mittal Journal: Transl Psychiatry Date: 2019-09-16 Impact factor: 6.222